Cost-effectiveness of endorectal magnetic resonance imaging for the staging of prostate cancer.

Academic radiology

Volumn 3 Suppl 1, Issue , 1996, Pages

  Langlotz, C P ^a   Schnall, M D ^a   Malkowicz, S B ^a   Schwartz, J S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER STAGING; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; ECONOMICS; HUMAN; MALE; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROSTATE; PROSTATE TUMOR; QUALITY ADJUSTED LIFE YEAR; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; SURVIVAL RATE;

COST-BENEFIT ANALYSIS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MODELS, ECONOMIC; NEOPLASM STAGING; PROSTATE; PROSTATIC NEOPLASMS; QUALITY-ADJUSTED LIFE YEARS; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE;

MLCS; MLOWN;

EID: 0030118139     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1076-6332(96)80472-7     Document Type: Article

References (0)